News About: Pharm. Industry
SK Chemicals launches Korea’s 13th new drug
SK Chemicals announced on November 1 its release of M-vix (mirodenafil), a homegrown impotence treatment. Its initial target is to record 10 billion won in sales next year.
Demonstrating the strength of the country...
Drug makers feel relieved over stronger Korean won
Korean pharmaceutical firms are breathing a sign of relief as the Korean won remains strong against major currencies, in the midst of external negative factors – government’s relented price cut and rebate scandal.
...
Delay of generics' license will hurt pharmaceutical sector
The government's plan to deny a local pharmaceutical company the license to sell generic drugs for at least two years under the proposed revision of the Pharmaceutical Affairs Law stirred heated debate in a government...
Dong-A Shareholders vote against Kang-Korea Alcohol's 5 nominees
Shareholders of Dong-A Pharmaceutical voted against all of five Kang-Korea Alcohol director nominees at the October 31 EGM - Jee Yong-seok Jee, Park Sun-keun, Jung Eun-sup, Lee Jun-haeng and Park Jeong-sam, a company ...
Bioprocess scientists and executives gathers in Seoul
An international bioprocess convention has been held between October 31 and November 2 to help explore potential manufacturing capabilities & capacities in Asia's fast growing bioprocessing industry.
The BioProcess...
KPMA mulls measures to assist seminars in bona fide
The Korea Pharmaceutical Manufacturers Association is now gauging the gravity of the impact that the Fair Trade Commission's wide graft probe would have on the local pharmaceutical industry, while it is studying to pr...
Astellas's Vesicare to be launched soon
Astellas Pharma Korea said on October 29 that Vesicare (solifenacin succinate) for the treatment of the overactive bladder (OAB) with the indication of urinary frequency, urgency and urge incontinence associated with ...
Hanmi targets W500 billion in sales this year
Hanmi Pharm aims to achieve 500 billion won in this year's sales, a company official said recently.
During the third quarter of this year, Hanmi reported that it earned 14.7 billion won on the largest sales of 135....
Government to lower insurance prices of 5 drugs
The Ministry of Health and Welfare announced on October 28 that insurance prices of five items, including GSK's Hepsera tablets 10 mg, will be reduced from November 1.
According to the ministry, 130 items will ...
10 Pharmaceutical firms face fines for rebates
The Free Trade Commission would announce penalties for 10 pharmaceutical makers each on November 2 after calculating sales improperly raised through illegal means.
Industry sources expect some of them would face m...
